找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Breast Diseases; Ismail Jatoi (Head),Manfred Kaufmann (Breast Unit Book 2010 Springer-Verlag Berlin Heidelberg 2010 Cancer

[復(fù)制鏈接]
樓主: 休耕地
51#
發(fā)表于 2025-3-30 11:19:48 | 只看該作者
Mattea Linder,Gunter von Minckwitzf jeden innerhalb und au?erhalb der Gesch?ftswelt zu: Wie der Mathematiker Poincaré bemerkte, tragen wir alle ein Bild von der Welt in unserem Kopf. Die Frage ist nur, welches Bild? Die Antwort darauf kann den Unterschied zwischen guten und schlechten Entscheidungen ausmachen.
52#
發(fā)表于 2025-3-30 15:17:25 | 只看該作者
Breast Imaging,he BI-RADS-standardized lexicon should be understood by referring physicians and will be used throughout this chapter. The latest edition of BI-RADS includes ultrasound and breast magnetic resonance imaging (MRI).
53#
發(fā)表于 2025-3-30 19:24:11 | 只看該作者
Surgical Considerations in the Management of Primary Invasive Breast Cancer,ors were extirpated before they spread through the lymphatics. Halsted also maintained that the extent of both the MT and axillary dissection were important determinants of outcome. Therefore, breast cancer recurrence and distant metastases were often attributed to inadequate surgery.
54#
發(fā)表于 2025-3-30 23:34:47 | 只看該作者
55#
發(fā)表于 2025-3-31 04:31:04 | 只看該作者
56#
發(fā)表于 2025-3-31 08:15:35 | 只看該作者
Endocrine Therapy,ch synthetic oestrogens became some of the first addivive systemic therapies for breast cancer and it wasn’t until the early 1970s that the first systemic anti-oestrogen, tamoxifen, came into clinical practice (.). Tamoxifen, largely overtook additive oestrogen therapy, not due to increased efficacy
57#
發(fā)表于 2025-3-31 10:18:05 | 只看該作者
Book 2010rld. Yet, it is worth noting that the management of breast cancer is now largely predicated on evidence-based medicine. Several large, randomized prospective trials have demonstrated the ef? cacy of breast cancer screening and chemoprevention. Other large trials have addressed the impact of systemic
58#
發(fā)表于 2025-3-31 14:24:00 | 只看該作者
59#
發(fā)表于 2025-3-31 20:05:02 | 只看該作者
60#
發(fā)表于 2025-4-1 00:25:12 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 11:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阜康市| 延长县| 馆陶县| 会宁县| 灵宝市| 商都县| 舒兰市| 攀枝花市| 礼泉县| 五华县| 辽宁省| 中阳县| 中卫市| 汉源县| 安吉县| 长治县| 呈贡县| 三亚市| 曲沃县| 白玉县| 周宁县| 白水县| 含山县| 泾川县| 南昌县| 镇远县| 鄂托克旗| 商水县| 阳原县| 时尚| 寻乌县| 区。| 高安市| 昭觉县| 玛纳斯县| 腾冲县| 平安县| 青田县| 夏邑县| 慈利县| 且末县|